Bone Marrow Transplantation News

“With great power comes great responsibility.”

Several clinicians will be honored at this year’s Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, scheduled for Feb. 15-19 in Orlando.

NEW ORLEANS — A regimen containing post-transplant cyclophosphamide significantly lowered graft-versus-host disease risk among adults who underwent reduced-intensity allogeneic hematopoietic stem cell transplant, study results showed.

NEW ORLEANS — Consolidation therapy with high-dose chemotherapy followed by hematopoietic stem cell transplant significantly prolonged PFS among adults with primary central nervous system lymphoma, according to study results.

NEW ORLEANS — Most hematopoietic stem cell transplant recipients received at least one dose of COVID-19 vaccine, according to single-institution study results presented at ASH Annual Meeting and Exposition.

ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.

This year’s ASH Annual Meeting and Exposition spotlighted practice-changing research in malignant and benign hematology.

NEW ORLEANS — Utilization of hematopoietic stem cell transplantation for acute myeloid leukemia has increased over time but remains far below optimal levels, according to study results presented at ASH Annual Meeting and Exposition.

Bone marrow transplant and cellular therapies are the only known curative therapy for many patients with hematologic malignancies or other disorders of blood and immune systems.

Bruce Blazar, MD, will receive the E. Donnall Thomas Lecture and Prize at this year’s ASH Annual Meeting and Exposition.